Companies Cryptocurrencies
Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc
Exchange: NasdaqCM
IPO Date: 27/07/2018
CEO: Mr. William Stilley
Biotechnology Healthcare 🔗
  • ADIL
  • 3.88
  • 79339016
    market cap
  • -0.1099999
If you bought

shares of Adial Pharmaceuticals Inc (ADIL) on
You would have made
Old Price $12 Current Price $12

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. The company is headquartered in Charlottesville, Virginia and currently employs 3 full-time employees. The firm is focused on the development of a therapeutic agent for the treatment of alcohol use disorder (AUD). Its lead drug product is AD04. AD04 is a selective serotonin-3 antagonist. AD04 can also be used for the treatment of other addictive disorders, such as obesity, smoking, and drug addiction. The firm has completed a Phase-II clinical trials of AD04.

Address: 1180 Seminole Trl Ste 495 Charlottesville VIRGINIA 22901

Stay updated.